BOPPY-based novel fluorescent dopamine D2 and D3 receptor ligands

被引：9
|
作者：
Elek, Milica [1 ]
Dubiel, Mariam [1 ]
Mayer, Laura [2 ]
Zivkovic, Aleksandra [1 ]
Mueller, Thomas J. J. [2 ]
Stark, Holger [1 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Organ Chem, Univ Str 1, D-40225 Dusseldorf, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2022年 / 59卷
关键词：
Dopamine; BOPPY; D2R; D3R; Fluorescence; Ligands; HIGHLY FLUORESCENT; HIGH-AFFINITY; BODIPY DYES; D3; SCHIZOPHRENIA; BIOLOGY; BINDING; PROBES; TARGET;
D O I：
10.1016/j.bmcl.2022.128573
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Dopamine is one of the crucial neurotransmitters in the human brain. Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D-2 and D-3 receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally related pyridine-based moieties. We used BOPPY labelling of well-described D2R/D3R pharmacophores to obtain ligands with moderate to low nanomolar binding affinities as well as low to excellent quantum yields for bright fluorescence ligands. To best of our knowledge, this is the first report on the application of BOPPY fluorophores to GPCR ligands. This approach offers a general applicable way for fluorescence labelling via primary aliphatic amine elements.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Dopamine D1, D2 and D3 receptor genes in alcohol dependence
    Sander, T
    Harms, H
    Podschus, J
    Finckh, U
    Nickel, B
    Rolfs, A
    Rommelspacher, H
    Schmidt, LG
    PSYCHIATRIC GENETICS, 1995, 5 (04) : 171 - 176
  • [32] MEDI 48-Tuning affinity on a tropane framework for dopamine D2/D3 receptor subtype ligands
    Paul, Noel M.
    Floresca, Christina Z.
    Taylor, Michelle
    Luedtke, Robert R.
    Deschamps, Jeffrey R.
    Newman, Amy H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [33] Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA
    D'Souza, U
    McGuffin, P
    Buckland, PR
    NEUROPHARMACOLOGY, 1997, 36 (11-12) : 1689 - 1696
  • [34] Dopamine D3 receptor ligands with antagonist properties
    Hackling, AE
    Stark, H
    CHEMBIOCHEM, 2002, 3 (10) : 946 - 961
  • [35] Affinity and selectivity determinants of bitropic ligands targeting D2 and D3 dopamine receptors
    Hayatshahi, Hamed
    Luedtke, Robert
    Liu, Jin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [36] Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands
    Laszlovszky, I
    Acs, T
    Kiss, B
    Domány, G
    PHARMAZIE, 2001, 56 (04): : 287 - 289
  • [37] Factors influencing d3 vs d2 dopamine receptor subtype selectivity
    Luedtke, R.
    Hayatshahi, H.
    Griffin, S.
    Taylor, M.
    Xu, K.
    Liu, J.
    Mach, R.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 249 - 249
  • [38] Advances and challenges in the search for D2 and D3 dopamine receptor selective compounds
    Moritz, Amy E.
    Free, R. Benjamin
    Sibley, David R.
    CELLULAR SIGNALLING, 2017, 41 : 75 - 81
  • [39] Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
    Wiers, C. E.
    Towb, P. C.
    Hodgkinson, C. A.
    Shen, P-H
    Freeman, C.
    Miller, G.
    Lindgren, E.
    Shokri-Kojori, E.
    Demiral, S. B.
    Kim, S. W.
    Tomasi, D.
    Sun, H.
    Wang, G-J
    Goldman, D.
    Volkow, N. D.
    MOLECULAR PSYCHIATRY, 2018, 23 (08) : 1711 - 1716
  • [40] D2/D3 dopamine receptor heterodimers exhibit unique functional properties
    Scarselli, M
    Novi, F
    Schallmach, E
    Ling, RW
    Baragli, A
    Colzi, A
    Griffon, N
    Corsini, GU
    Sokoloff, P
    Levenson, R
    Vogel, Z
    Maggio, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 30308 - 30314
12345